These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31330379)

  • 21. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
    Senf P; Schmitz B; Holtkamp M; Janz D
    Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accidental injuries in patients with generalized tonic-clonic seizures. A multicenter, observational, cross-sectional study (QUIN-GTC study).
    Salas-Puig X; Iniesta M; Abraira L; Puig J;
    Epilepsy Behav; 2019 Mar; 92():135-139. PubMed ID: 30658321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy.
    Ascoli M; Mastroianni G; Gasparini S; Striano P; Cianci V; Neri S; Bova V; Mammì A; Gambardella A; Labate A; Aguglia U; Ferlazzo E
    Expert Rev Neurother; 2021 Nov; 21(11):1265-1273. PubMed ID: 33993822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road.
    Baheti N; Rathore C; Bansal AR; Shah S; Veedu HK; Prakash S; Kanhere K; Jaiswal SK; Jukkarwala A; Murthy JMK; Radhakrishnan K
    Seizure; 2021 Nov; 92():112-117. PubMed ID: 34496330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA; García VF; Astencio AG; Cuartas VB
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
    Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
    Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile myoclonic epilepsy.
    Alfradique I; Vasconcelos MM
    Arq Neuropsiquiatr; 2007 Dec; 65(4B):1266-71. PubMed ID: 18345445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study.
    Camfield CS; Camfield PR
    Neurology; 2009 Sep; 73(13):1041-5. PubMed ID: 19786695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic analysis of juvenile myoclonic epilepsy in Indian families.
    Jain S; Tripathi M; Srivastava AK; Narula A
    Acta Neurol Scand; 2003 May; 107(5):356-62. PubMed ID: 12713528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R
    Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
    Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
    Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.
    Welty TE
    Paediatr Drugs; 2006; 8(5):303-10. PubMed ID: 17037947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial.
    Daneshyar S; Ghiasian M; Moradi S; Khanlarzadeh E
    Caspian J Intern Med; 2022; 13(3):617-622. PubMed ID: 35974938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
    Gesche J; Hjalgrim H; Rubboli G; Beier CP
    Epilepsy Res; 2021 Feb; 170():106547. PubMed ID: 33421702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.
    Cerulli Irelli E; Morano A; Orlando B; Salamone EM; Fanella M; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Acta Neurol Scand; 2022 Mar; 145(3):314-321. PubMed ID: 34791656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.